Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

The purpose of the study was to determine the long-term safety and effectiveness of high-dose immunosuppressive therapy (HDIT) followed by autologous hematopoietic cell transplantation (AHCT) in advanced multiple sclerosis (MS). Total body irradiation, cyclophosphamide, and antithymocyte globulin we...

Full description

Bibliographic Details
Main Authors: Bowen, James D., Kraft, George H., Wundes, Annette, Guan, QingYan, Maravilla, Kenneth R., Gooley, Theodore A., McSweeney, Peter A., Pavletic, Steven Z., Openshaw, Harry, Storb, Rainer, Wener, Mark, McLaughlin, Bernadette A., Henstorf, Gretchen R., Nash, Richard A.
Format: Online
Language:English
Published: 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276694/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276694/

Similar Items